Concept illustration of GLP-1 agonist.

UC San Diego Health News

GLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease

Semaglutide improves liver scarring in advanced MASH clinical trial result
Concept illustration of GLP-1 agonist.

Latest Press Releases

View All
Concept illustration of GLP-1 agonist.

July 16, 2026 | Leslie Aquinde

GLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease

GLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large global trial study.

Aerial image of hospital facility in Escondido.

July 2, 2026 | Kim Coutts

Palomar Health and UC San Diego Health Form Joint Powers Authority

Palomar Health and UC San Diego Health have formed a Joint Powers Authority (JPA) to stabilize and enhance patient care in North San Diego County.

Wide view of a hospital nursing station in between two corridors. People are shown in motion in each corridor and a person is bent over a row of computers in the glass-walled nursing station.

June 25, 2026 | Jeanna Vazquez

Study: Leveraging AI to Enhance How Physicians Approach Sepsis Care

Researchers find by utilizing artificial intelligence (AI), physicians can reduce the time and resources needed to develop accurate and efficient assessments for sepsis care.

Leading the Way in San Diego

At UC San Diego Health, you'll experience compassionate care that puts you first. From diagnosis to recovery and beyond, our experts are leading the way in innovation and bringing you the latest in treatment options.

See the Benefits of Choosing UC San Diego Health